Multiple System Atrophy Latest Advances

Elevated plasma neurofilament light chain in isolated REM sleep behavior disorder: Associations with neurogenic orthostatic hypotension and implications for phenoconversion.

Journal: Journal of Parkinson's disease

Published: April 15, 2026

Different brain spatial metabolic patterns characterizing different subtypes of multiple system atrophy.

Journal: Journal of Parkinson's disease

Published: April 15, 2026

Cross-disease genetic and epigenetic architecture of the MOBP locus shows convergence in ALS-PSP.

Journal: bioRxiv : the preprint server for biology

Published: April 03, 2026

Pathology and genetics in a global cohort of Parkinsonian Disorders.

Journal: medRxiv : the preprint server for health sciences

Published: April 03, 2026

Cytotoxic T cell recognition of α-synuclein drives pathogenic immune responses in multiple system atrophy.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 30, 2026

Retraction Note: Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy.

Journal: Acta neuropathologica communications

Published: March 28, 2026

Molecular Imaging of Tau and α-Synuclein Pathologies: Technical Advances, Challenges, and Opportunities

Journal: Fortschritte der Neurologie-Psychiatrie

Published: March 27, 2026

Astrocytic FABP5 drives non-cell-autonomous oligodendrocyte injury in multiple system atrophy by promoting TNF signaling and ferroptotic stress.

Journal: Redox biology

Published: March 23, 2026

Lipid Acyl Chain-Driven α-Synuclein Fibril Polymorphisms and Neuronal Pathologies.

Journal: bioRxiv : the preprint server for biology

Published: February 27, 2026

Metabolomic Cerebrospinal Fluid Biomarkers for the Diagnosis of Atypical Parkinsonian Syndromes.

Journal: International journal of molecular sciences

Published: February 26, 2026

Quantitative measures of total and phosphorylated alpha-synuclein in skin tissue as potential biomarkers for synucleinopathies.

Journal: Journal of Parkinson's disease

Published: February 26, 2026

Large-scale bidirectional arrayed genetic screens identify OXR1 and EMC4 as modifiers of αSynuclein aggregation.

Journal: FEBS open bio

Published: February 19, 2026

Multiple System Atrophy Latest Advances

Find the Latest Research About Multiple System Atrophy

Elevated plasma neurofilament light chain in isolated REM sleep behavior disorder: Associations with neurogenic orthostatic hypotension and implications for phenoconversion.

Elevated plasma neurofilament light chain in isolated REM sleep behavior disorder: Associations with neurogenic orthostatic hypotension and implications for phenoconversion.

Different brain spatial metabolic patterns characterizing different subtypes of multiple system atrophy.

Different brain spatial metabolic patterns characterizing different subtypes of multiple system atrophy.

Cross-disease genetic and epigenetic architecture of the MOBP locus shows convergence in ALS-PSP.

Cross-disease genetic and epigenetic architecture of the MOBP locus shows convergence in ALS-PSP.

Pathology and genetics in a global cohort of Parkinsonian Disorders.

Pathology and genetics in a global cohort of Parkinsonian Disorders.

Cytotoxic T cell recognition of α-synuclein drives pathogenic immune responses in multiple system atrophy.

Cytotoxic T cell recognition of α-synuclein drives pathogenic immune responses in multiple system atrophy.

Retraction Note: Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy.

Retraction Note: Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy.

Molecular Imaging of Tau and α-Synuclein Pathologies: Technical Advances, Challenges, and Opportunities

Molecular Imaging of Tau and α-Synuclein Pathologies: Technical Advances, Challenges, and Opportunities

Astrocytic FABP5 drives non-cell-autonomous oligodendrocyte injury in multiple system atrophy by promoting TNF signaling and ferroptotic stress.

Astrocytic FABP5 drives non-cell-autonomous oligodendrocyte injury in multiple system atrophy by promoting TNF signaling and ferroptotic stress.

Lipid Acyl Chain-Driven α-Synuclein Fibril Polymorphisms and Neuronal Pathologies.

Lipid Acyl Chain-Driven α-Synuclein Fibril Polymorphisms and Neuronal Pathologies.

Metabolomic Cerebrospinal Fluid Biomarkers for the Diagnosis of Atypical Parkinsonian Syndromes.

Metabolomic Cerebrospinal Fluid Biomarkers for the Diagnosis of Atypical Parkinsonian Syndromes.

Quantitative measures of total and phosphorylated alpha-synuclein in skin tissue as potential biomarkers for synucleinopathies.

Quantitative measures of total and phosphorylated alpha-synuclein in skin tissue as potential biomarkers for synucleinopathies.

Large-scale bidirectional arrayed genetic screens identify OXR1 and EMC4 as modifiers of αSynuclein aggregation.

Large-scale bidirectional arrayed genetic screens identify OXR1 and EMC4 as modifiers of αSynuclein aggregation.